Psychiatry · New York, NY
NPI
1093860975
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
60 Sutton Pl S Ste 1cn
New York, NY, 10022
Phone (212) 751-5072
Medicare paid, 2024
$373K
3,759 services
Medicare patients, 2024
167
Average age 74
Drug cost, 2024
$247K
3,521 prescriptions
Company payments, 2025
$219
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan Manevitz was code 90836 (psychotherapy - nongroup), 1,401 times for 142 patients. In total Alan Manevitz billed 3,759 services in 14 codes, and Medicare paid $373K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90836 Psychotherapy - Nongroup | Office | 1,401 | 142 | $72.95 | $102K |
| 99213 Office E&M - Established | Office | 742 | 126 | $74.28 | $55K |
| 99214 Office E&M - Established | Office | 715 | 86 | $105.17 | $75K |
| 90868 Treatment - Miscellaneous | Office | 706 | 30 | $163.83 | $116K |
| 90847 Psychotherapy - Nongroup | Office | 97 | 17 | $82.82 | $8,034 |
| 90792 Psychotherapy - Nongroup | Office | 41 | 41 | $146.66 | $6,013 |
| 90867 Treatment - Miscellaneous | Office | 22 | 20 | $266.28 | $5,858 |
By year: 2022 $351K for 3,472 services; 2023 $405K for 4,045 services; 2024 $373K for 3,759 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan Manevitz prescribed most often to Medicare patients was Clonazepam, with 384 prescriptions and refills. In total Alan Manevitz wrote 3,521 Medicare prescriptions that cost $247K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 384 | 395 | 50 | $2,882 |
| Quetiapine Fumarate Generic | 249 | 291 | 44 | $3,356 |
| Alprazolam Generic | 215 | 215 | 33 | $2,696 |
| Zolpidem Tartrate Generic | 163 | 164 | 25 | $1,019 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 140 | 142 | 18 | $3,918 |
| Bupropion Xl Bupropion Hcl | 136 | 189 | 23 | $2,105 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 135 | 198 | 23 | $7,333 |
| Duloxetine Hcl Generic | 134 | 189 | 13 | $2,317 |
| Trazodone Hcl Generic | 116 | 130 | 13 | $1,282 |
| Fluoxetine Hcl Generic | 109 | 201 | 18 | $1,008 |
| Olanzapine Generic | 100 | 116 | 14 | $2,605 |
| Lamotrigine Generic | 81 | 121 | 14 | $725 |
| Escitalopram Oxalate Generic | 72 | 112 | 14 | $1,056 |
| Diazepam Generic | 70 | 70 | 12 | $191 |
| Lorazepam Generic | 67 | 71 | Under 11 | $726 |
Brand drugs: - claims; generic drugs: 3,216 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan Manevitz $219 ($219 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alkermes, Inc. with $56.74.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.